Cargando…
The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia
Acute myeloid leukemia (AML) is a highly heterogeneous disease and internal tandem duplication mutation in FMS-like tyrosine-kinase-3 (FLT3-ITD) has a negative impact on outcome. Finding effective treatment regimens is desperately needed. In this study, we explored the inhibitory effect and mechanis...
Autores principales: | Li, Xia, Yin, Xiufeng, Wang, Huafeng, Huang, Jiansong, Yu, Mengxia, Ma, Zhixin, Li, Chenying, Zhou, Yile, Yan, Xiao, Huang, ShuJuan, Jin, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355052/ https://www.ncbi.nlm.nih.gov/pubmed/28061447 http://dx.doi.org/10.18632/oncotarget.14463 |
Ejemplares similares
-
Correction: The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia
por: Li, Xia, et al.
Publicado: (2019) -
ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3
‐ITD
por: Qian, Yu, et al.
Publicado: (2023) -
Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells
por: Chen, Jian, et al.
Publicado: (2017) -
Homoharringtonine Synergized with Gilteritinib Results in the Downregulation of Myeloid Cell Leukemia-1 by Upregulating UBE2L6 in FLT3-ITD-Mutant Acute Myeloid (Leukemia) Cell Lines
por: Cai, Jiayi, et al.
Publicado: (2021) -
Homoharringtonine Combined with the Heat Shock Protein 90 Inhibitor IPI504 in the Treatment of FLT3-ITD Acute Myeloid Leukemia
por: Wu, Zhaoxing, et al.
Publicado: (2019)